China Charges Ex-AstraZeneca China Chief

Leon Wang, previously the head of AstraZeneca's operations in China, has now been formally charged. He has been in detention since October 2024, with the pharmaceutical company confirming this development on Wednesday, February 11, 2026. This legal action comes after AstraZeneca's November update, which revealed that two other former employees in China had been indicted. These individuals include a former executive vice president and another senior employee, both charged by prosecutors.

The Financial Times initially reported that Wang was the executive facing charges. The specifics of the alleged offenses leading to Wang's detention and subsequent charging have not been detailed in the provided information. The situation highlights ongoing scrutiny of pharmaceutical business practices within China.